A new mouse model of late infantile Batten disease may help to efficiently investigate personalized  therapies, a study suggests.
Ashraf Malhas, PhD
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Ashraf Malhas, PhD
In children with late infantile neuronal ceroid lipofuscinosis 5 (CLN5), cognitive difficulties are early clinical markers of this condition,…
A deficiency of the progranulin protein leads to abnormalities in lysosomal function and may explain some of the molecular…
Disruption of cilia, hair-like structures extending from the surface of cells, may play a role in Batten disease…
Neural stem cells derived from people with Batten disease can be used as a “disease model” to evaluate new…